From Data to Decisions: How GA-map® Uses AI to Simplify Clinical Interpretation of Microbiome Results

What is GA-map® Dysbiosis Test AInsight?

Gut microbiome analysis is rapidly emerging as a valuable addition to modern diagnostics, offering new perspectives on gastrointestinal health, inflammation, and chronic disease. However, translating complex microbial data into clinically meaningful insights remains a key challenge for healthcare professionals.

To address this gap, Genetic Analysis AS has developed GA-map® Dysbiosis Test AInsight — an AI-powered interpretation platform designed to support clinicians in understanding and acting upon microbiome test results from the GA-map® Dysbiosis Test.

By combining clinically validated microbiome analysis with advances in artificial intelligence, the platform helps transform complex bacterial profiles into structured, actionable insights that can support clinical decision-making.

Understanding the GA-map® Dysbiosis Test

Clinically Validated Microbiome Analysis

The GA-map® Dysbiosis Test is a CE-IVD marked molecular diagnostic assay designed to assess the composition of the gut microbiota by targeting a predefined panel of clinically relevant bacterial markers.

Using a molecular probe-based technology, the test measures deviations in the abundance of specific bacterial groups associated with gut health and disease. The results are summarized in a clinically validated Dysbiosis Index (DI), providing an objective measurement of imbalance in the intestinal microbiota.

Integrated Reference Range for Standardized Interpretation

Key advantages of the GA-map® Dysbiosis Test include clinical validation across multiple patient cohorts, standardized and reproducible methodology, and an integrated reference range derived from an independent, clinically defined healthy population.

Advantages of a Standardized Microbiome Testing Platform

Unlike many commercial microbiome tests, the GA-map® Dysbiosis Test operates as a standardized diagnostic platform, meaning that both the analytical targets and the reference ranges are predefined and validated. This structure ensures that the resulting data are suitable for routine use and clinical interpretation.

Microbiome Analysis in Holistic Diagnostics: Promise and Complexity

As interest in personalized and preventive medicine grows, microbiome profiling is increasingly being incorporated into holistic diagnostic frameworks. Research continues to link microbial imbalances with conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), metabolic disorders, and immune dysregulation.

Challenges in Clinical Microbiome Test Interpretation

Despite this potential, microbiome data interpretation remains a barrier to adoption in routine clinical practice. Microbial datasets are inherently multidimensional, and understanding how deviations in bacterial abundance relate to clinical outcomes requires navigating a rapidly evolving body of scientific literature.

Advances in AI for Microbiome Clinical Decision Support

Recent developments in artificial intelligence — particularly large language models — have introduced new opportunities to assist clinicians in managing complex biomedical information.

AI systems can now synthesize large volumes of curated scientific data and extract relevant associations in a structured manner. When implemented responsibly, such tools have the potential to enhance efficiency, improve consistency in interpretation, and support evidence-based decision-making without replacing clinical expertise.

How AI Powers GA-map® Dysbiosis Test AInsight

AI Language Model Built on curated Bacteria Compendium

GA-map® Dysbiosis Test AInsight utilizes an AI language model to extract and structure relevant information from the Bacteria Compendium — a curated internal knowledge base containing clinical associations published in peer-reviewed publications for each bacterial marker measured by the test.

Controlled Information Retrieval in a Closed Platform

Because the AInsight operates within a closed analytical system, the AI model is restricted to retrieving information exclusively from this validated source. This controlled framework helps ensure that the generated interpretations remain aligned with the scientific evidence underpinning the microbiome assay.

Features of the AInsight Interpretations

• Automated interpretation of individual microbiome profiles
• Scalable generation of single or bulk reports
• Structured summaries of bacterial deviations
• Contextualized associations based on curated scientific literature
• Suggestions for clinically relevant follow-up assessments

Transforming Microbiome Data into Actionable Clinical Insight

By combining standardized microbiome diagnostics with AI-assisted interpretation, Genetic Analysis AS aims to reduce the complexity of microbiome data analysis and make clinically validated gut health insights more accessible to healthcare providers.

As microbiome science continues to evolve, tools such as GA-map® Dysbiosis Test AInsight may play an important role in enabling more efficient, data-informed approaches to gastrointestinal health management — bridging the gap between microbial profiling and actionable clinical insight.